ENO2 and neoplasm: This TKO tumor exhibited increased levels of the NEPC markers CHGA, SYP, and NSE.[44] We assessed the expression of p53, pten, rb1 in PC3 and C4‐2 cells with SFT2D2‐TBX19 knockdown and overexpression.